nodes	percent_of_prediction	percent_of_DWPC	metapath
Valrubicin—urinary bladder cancer—vaginal cancer	0.993	1	CtDrD
Valrubicin—TOP2A—uterine cervix—vaginal cancer	0.00149	0.201	CbGeAlD
Valrubicin—TOP2A—endometrium—vaginal cancer	0.00134	0.182	CbGeAlD
Valrubicin—TOP2A—mammalian vulva—vaginal cancer	0.0013	0.176	CbGeAlD
Valrubicin—TOP2A—uterus—vaginal cancer	0.00124	0.168	CbGeAlD
Valrubicin—TOP2A—female gonad—vaginal cancer	0.00101	0.137	CbGeAlD
Valrubicin—TOP2A—vagina—vaginal cancer	0.00101	0.136	CbGeAlD
